Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
CancerTools Cat# 161904, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7591954 PMID:10723130 PMID:10929426 PMID:15585611 PMID:17409424 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
CancerTools |
161904 |
BTO:BTO_0006204, CLO:CLO_0002177, EFO:EFO_0002150, MCCL:MCC:0000124, CLDB:cl625, CLDB:cl626, CLDB:cl627, CLDB:cl629, 4DN:4DNSRDD5W2FZ, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-47, BCRJ:0408, BioGRID_ORCS_Cell_line:583, BioSample:SAMN01821542, BioSample:SAMN01821619, BioSample:SAMN03471873, BioSample:SAMN10988361, cancercelllines:CVCL_0235, CancerTools:161904, CCRID:1101HUM-PUMC000337, Cell_Model_Passport:SIDM01546, ChEMBL-Cells:CHEMBL3308071, ChEMBL-Targets:CHEMBL613852, CLS:300140, Cosmic:687941, Cosmic:874612, Cosmic:877458, Cosmic:979706, Cosmic:982278, Cosmic:1152536, Cosmic:2520633, DepMap:ACH-000234, DSMZ:ACC-54, DSMZCellDive:ACC-54, ECACC:93120819, EGA:EGAS00001000610, ENCODE:ENCBS074UKQ, ENCODE:ENCBS461KDA, ENCODE:ENCBS611WID, ENCODE:ENCBS768KGZ, ENCODE:ENCBS787YGO, GEO:GSM374478, GEO:GSM886903, GEO:GSM887968, IARC_TP53:30022, ICLC:HTL95029, IGRhCellID:Caki2, IZSLER:BS TCL 8, KCLB:30047, LiGeA:CCLE_157, PharmacoDB:Caki2_164_2019, PRIDE:PXD000335, PRIDE:PXD003105, Progenetix:CVCL_0235, PubChem_Cell_line:CVCL_0235, Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-02-07 08:55:39 |
275 |
1321N1
Resource Report
Resource Website
10+ mentions
Contaminated
|
RRID:CVCL_0110
|
Homo sapiens (Human)
|
Astrocytoma
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Contaminated. Grand-parent cell line (U-118MG) has been shown to be a U-138MG derivative..
|
PMID:17254797 PMID:20215515 PMID:22460905 PMID:25877200 PMID:29887596 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Male |
1321-N1, 1321 N1 |
|
|
BTO:BTO_0003605, CLO:CLO_0001072, MCCL:MCC:0000001, CLDB:cl5, BioSample:SAMN03471026, cancercelllines:CVCL_0110, Cell_Model_Passport:SIDM01967, DepMap:ACH-001000, ECACC:86030402, GEO:GSM827421, GEO:GSM886835, GEO:GSM887898, GEO:GSM1374373, GEO:GSM3034453, GEO:GSM3034454, GEO:GSM3034455, GEO:GSM3034456, GEO:GSM3034457, GEO:GSM3034458, IARC_TP53:21148, IZSLER:BS TCL 109, LINCS_LDP:LCL-1393, NCBI_Iran:C118, PharmacoDB:1321N1_2_2019, Progenetix:CVCL_0110, Wikidata:Q54581478 |
cvcl_d317 |
|
CVCL_0110 |
2026-02-07 08:58:29 |
13 |
23132/87
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-201, RRID:CVCL_1046
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8100658 PMID:11668190 PMID:20164919 PMID:20215515 PMID:22460905 PMID:24807215 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
23132-87, 2313287, St 23132, St23132, 23132 |
DSMZ |
ACC-201 |
CLO:CLO_0001202, EFO:EFO_0006528, CLDB:cl38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:822, BioSample:SAMN03470944, BioSample:SAMN03473375, BioSample:SAMN10988573, cancercelllines:CVCL_1046, Cell_Model_Passport:SIDM00980, ChEMBL-Cells:CHEMBL3308702, ChEMBL-Targets:CHEMBL1075382, Cosmic:910924, Cosmic:1995324, Cosmic:2484956, Cosmic-CLP:910924, DepMap:ACH-000948, DSMZ:ACC-201, DSMZCellDive:ACC-201, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910924, GEO:GSM827572, GEO:GSM886838, GEO:GSM887901, GEO:GSM1374371, GEO:GSM1374372, GEO:GSM1669566, IARC_TP53:21150, LiGeA:CCLE_415, LINCS_LDP:LCL-1532, PharmacoDB:2313287_13_2019, PRIDE:PXD030304, Progenetix:CVCL_1046, PubChem_Cell_line:CVCL_1046, Wikidata:Q54583395 |
|
|
CVCL_1046 |
2026-02-07 08:58:46 |
1 |
22Rv1
Resource Report
Resource Website
500+ mentions
|
RRID:CVCL_1045
|
Homo sapiens (Human)
|
Prostate carcinoma
|
Virology: Contains at least 10 integrated copies of xenotropic murine leukemia virus-related virus (XMRV) genome and produces a high titer of the virus (PubMed=19403664; PubMed=30629668)., Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:10462204 PMID:12725112 PMID:14518029 PMID:14518030 PMID:15486987 PMID:19403664 PMID:20164919 PMID:20215515 PMID:21248069 PMID:22460905 PMID:23117885 PMID:23671654 PMID:25877200 PMID:25984343 PMID:27271795 PMID:27397505 PMID:28145883 PMID:28928128 PMID:30629668 PMID:30787054 PMID:30894373 PMID:30971826 PMID:31006810 PMID:31068700 PMID:31395879 PMID:31978347 PMID:35839778 PMID:38892296
|
Cancer cell line
|
Male |
22RV1, 22Rv-1, 22rV1, CWR-22rv1, CWR22-Rv1, CWR22R-V1, CWR22-R1, CWR22Rv1, CWR22R |
|
|
BTO:BTO_0002999, CLO:CLO_0001199, CLO:CLO_0001200, EFO:EFO_0002095, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2505, BCRC:60545, BioGRID_ORCS_Cell_line:821, BioSample:SAMN03471600, BioSample:SAMN03472052, BioSample:SAMN05292447, BioSample:SAMN07710012, BioSample:SAMN07710013, BioSample:SAMN07710014, BioSample:SAMN07710015, BioSample:SAMN07710016, BioSample:SAMN07710017, BioSample:SAMN07710018, BioSample:SAMN10988315, cancercelllines:CVCL_1045, CCRID:3101HUMSCSP5022, CCRID:3101HUMTCHu100, CCRID:4201HUM-CCTCC00288, CCRID:5301HUM-KCB07031YJ, CCTCC:GDC0288, Cell_Model_Passport:SIDM00499, ChEMBL-Cells:CHEMBL3308004, ChEMBL-Targets:CHEMBL612657, CLS:305037, Cosmic:924100, Cosmic:1028699, Cosmic:1071480, Cosmic:1075276, Cosmic:1172629, Cosmic:1330911, Cosmic:1689707, Cosmic:1995323, Cosmic:2537791, Cosmic:2580126, Cosmic:2651766, Cosmic:2669170, Cosmic-CLP:924100, DepMap:ACH-000956, DSMZ:ACC-438, DSMZCellDive:ACC-438, ECACC:05092802, EGA:EGAS00001000978, ENCODE:ENCBS070BKF, ENCODE:ENCBS383WOY, ENCODE:ENCBS596KKM, ENCODE:ENCBS626QQL, ENCODE:ENCBS737IZN, ENCODE:ENCBS822DIG, GDSC:924100, GEO:GSM91926, GEO:GSM525793, GEO:GSM648815, GEO:GSM827396, GEO:GSM886837, GEO:GSM887900, GEO:GSM1374375, GEO:GSM1633317, GEO:GSM1633318, GEO:GSM1633319, GEO:GSM1669565, GEO:GSM3145592, GEO:GSM3145703, IARC_TP53:18887, IGRhCellID:22Rv1, KCB:KCB 200731YJ, LiGeA:CCLE_229, LINCS_LDP:LCL-1145, Lonza:1442, PharmacoDB:22RV1_12_2019, PRIDE:PXD030304, Progenetix:CVCL_1045, PubChem_Cell_line:CVCL_1045, Ubigene:YC-C012, Wikidata:Q54583380 |
cvcl_3967 |
|
CVCL_1045 |
2026-02-07 08:58:51 |
909 |
143B
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_2270
|
Homo sapiens (Human)
|
Osteosarcoma
|
Caution: Could be identical to HTK- (Cellosaurus=CVCL_2522)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2233717 PMID:19787792 PMID:21519327 PMID:22460905 PMID:23144859 PMID:25485619 PMID:25877200 PMID:26320182 PMID:26589293 PMID:26852163 PMID:29334376 PMID:30894373 PMID:31068700 PMID:36480329
|
Cancer cell line
|
Female |
143b, 143 B, 143B TK-, 143B.TK-, 143BTK-, 143TK-, HOS-143B, HOS-143b, GM05887, GM05887A |
|
|
BTO:BTO_0003167, CLO:CLO_0001084, CLO:CLO_0001088, CLO:CLO_0024221, EFO:EFO_0006355, CLDB:cl10, CLDB:cl11, ArrayExpress:E-MTAB-2706, ATCC:CRL-8303, BCRC:60439, BioGRID_ORCS_Cell_line:315, BioSample:SAMN03471904, cancercelllines:CVCL_2270, CCRID:1101HUM-PUMC000363, CCRID:4201HUM-CCTCC00076, CCTCC:GDC0076, Cell_Model_Passport:SIDM00804, ChEMBL-Cells:CHEMBL3307382, ChEMBL-Targets:CHEMBL614508, CLS:305232, Coriell:GM05887, Cosmic:1074398, Cosmic:1529910, Cosmic:2009541, DepMap:ACH-001001, ECACC:91112502, EGA:EGAS00001000610, GEO:GSM320829, GEO:GSM879206, GEO:GSM886836, GEO:GSM887899, GEO:GSM1914980, GEO:GSM1914981, GEO:GSM1914982, GEO:GSM1914983, GEO:GSM1915018, GEO:GSM1915019, GEO:GSM1915020, GEO:GSM1915021, GEO:GSM1915022, GEO:GSM2635309, GEO:GSM2635310, IARC_TP53:21149, IARC_TP53:27023, IZSLER:BS TCL 77, LINCS_LDP:LCL-1417, Lonza:136, PharmacoDB:143B_3_2019, PRIDE:PXD002425, Progenetix:CVCL_2270, PubChem_Cell_line:CVCL_2270, TOKU-E:132, Wikidata:Q54581813 |
cvcl_0312 |
|
CVCL_2270 |
2026-02-07 08:58:33 |
475 |
59M
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2291
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Caucasian., Part of: OCCP ovarian cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2653399 PMID:8795574 PMID:15677628 PMID:22460905 PMID:23415752 PMID:23839242 PMID:25230021 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27561551 PMID:28196595 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Female |
OAW59M, OAW 59M, 59 M |
|
|
CLO:CLO_0001428, EFO:EFO_0006358, CLDB:cl110, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, BioGRID_ORCS_Cell_line:498, BioSample:SAMN03472466, BioSample:SAMN10988041, cancercelllines:CVCL_2291, Cell_Model_Passport:SIDM01528, DepMap:ACH-000520, ECACC:89081802, EGA:EGAS00001000610, GEO:GSM313717, GEO:GSM887904, GEO:GSM1291125, GEO:GSM1374376, IARC_TP53:28342, LiGeA:CCLE_458, PharmacoDB:59M_21_2019, PRIDE:PXD003668, Progenetix:CVCL_2291, Wikidata:Q54604004 |
|
|
CVCL_2291 |
2026-02-07 08:59:23 |
3 |
5637
Resource Report
Resource Website
50+ mentions
|
RRID:CVCL_0126
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Part of: UBC-40 urothelial bladder cancer cell line index., Part of: ERK genetic alteration cell panel (ATCC TCP-1033)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:327080 PMID:571047 PMID:833871 PMID:3518877 PMID:6244232 PMID:6582512 PMID:7459858 PMID:7787250 PMID:8873383 PMID:9850064 PMID:11416159 PMID:11921286 PMID:12127398 PMID:15846775 PMID:16885334 PMID:17254797 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23401075 PMID:24035680 PMID:24367658 PMID:24459064 PMID:25997541 PMID:26055179 PMID:26972028 PMID:27141528 PMID:27270441 PMID:27397505 PMID:29732388 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
|
|
|
BTO:BTO_0003137, CLO:CLO_0001421, CLO:CLO_0050845, EFO:EFO_0002096, MCCL:MCC:0000018, CLDB:cl1, CLDB:cl105, CLDB:cl7118, AddexBio:C0002001/8, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-9, BCRC:60061, BCRJ:0026, BioGRID_ORCS_Cell_line:316, BioSample:SAMN01821610, BioSample:SAMN03472760, BioSample:SAMN03473359, BioSample:SAMN10987658, cancercelllines:CVCL_0126, CCRID:1101HUM-PUMC000242, CCRID:3101HUMTCHu01, CCRID:3101HUMTCHu1, Cell_Model_Passport:SIDM00807, ChEMBL-Cells:CHEMBL3308352, ChEMBL-Targets:CHEMBL612565, CLS:300105, Cosmic:687452, Cosmic:715695, Cosmic:760484, Cosmic:845565, Cosmic:846281, Cosmic:928819, Cosmic:943732, Cosmic:1016892, Cosmic:1046675, Cosmic:1093983, Cosmic:1285103, Cosmic:1285998, Cosmic:1927307, Cosmic:2050427, Cosmic:2057434, Cosmic:2301520, Cosmic:2444227, Cosmic:2685930, Cosmic:2700995, Cosmic-CLP:687452, DepMap:ACH-000905, DSMZ:ACC-35, DSMZCellDive:ACC-35, EGA:EGAS00001000978, FANTOM5_SSTAR:10418-106C4, GDSC:687452, GEO:GSM136228, GEO:GSM142303, GEO:GSM142309, GEO:GSM886840, GEO:GSM887903, GEO:GSM1374370, GEO:GSM1574578, GEO:GSM1669563, IARC_TP53:3717, ICLC:HTL01017, IGRhCellID:5637, KCLB:30009, LiGeA:CCLE_867, LINCS_HMS:50001, LINCS_LDP:LCL-1702, NCBI_Iran:C450, PharmacoDB:5637_20_2019, PRIDE:PXD003105, PRIDE:PXD030304, Progenetix:CVCL_0126, PubChem_Cell_line:CVCL_0126, RCB:RCB1191, RCB:RCB3676, SKY/M-FISH/CGH:17, TKG:TKG 0605, Ubigene:YC-C102, Wikidata:Q54603866 |
|
|
CVCL_0126 |
2026-02-07 08:59:32 |
55 |
639V
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_1048
|
Homo sapiens (Human)
|
Ureter urothelial carcinoma
|
Population: Caucasian., Part of: UBC-40 urothelial bladder cancer cell line index., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:66978 PMID:571047 PMID:748774 PMID:944089 PMID:3518877 PMID:6244232 PMID:6582512 PMID:6935474 PMID:8873383 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23401075 PMID:24035680 PMID:24367658 PMID:25997541 PMID:26589293 PMID:26621286 PMID:27397505 PMID:29732388 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
639v, 639-V, 639 V |
|
|
CLO:CLO_0001448, EFO:EFO_0002097, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-109, BioGRID_ORCS_Cell_line:499, BioSample:SAMN03473587, BioSample:SAMN10989559, cancercelllines:CVCL_1048, Cell_Model_Passport:SIDM00999, ChEMBL-Cells:CHEMBL3308703, ChEMBL-Targets:CHEMBL1075383, Cosmic:906798, Cosmic:923375, Cosmic:928821, Cosmic:1285104, Cosmic:1927315, Cosmic:2050428, Cosmic:2685931, Cosmic-CLP:906798, DepMap:ACH-000973, DSMZ:ACC-413, DSMZCellDive:ACC-413, EGA:EGAS00001000978, GDSC:906798, GEO:GSM827155, GEO:GSM886841, GEO:GSM887905, GEO:GSM1567846, GEO:GSM1574552, GEO:GSM1574584, GEO:GSM1669569, IARC_TP53:6601, IGRhCellID:639V, LiGeA:CCLE_355, LINCS_LDP:LCL-1943, PharmacoDB:639V_24_2019, PRIDE:PXD030304, Progenetix:CVCL_1048, PubChem_Cell_line:CVCL_1048, Wikidata:Q52155313 |
|
|
CVCL_1048 |
2026-02-07 08:59:34 |
2 |
697
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0079
|
Homo sapiens (Human)
|
Childhood B acute lymphoblastic leukemia
|
Population: Caucasian., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:6982733 PMID:7630190 PMID:7888679 PMID:9108419 PMID:9823951 PMID:10490826 PMID:11021758 PMID:11843816 PMID:15843827 PMID:20164919 PMID:20519628 PMID:20575032 PMID:21538216 PMID:22460905 PMID:25984343 PMID:26589293 PMID:27397505 PMID:29786757 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31160637 PMID:31305009 PMID:31978347 PMID:35124168 PMID:35354797 PMID:35839778
|
Cancer cell line
|
Male |
Line 697, EU-3, Emory University-3 |
|
|
BTO:BTO_0001969, CLO:CLO_0001008, EFO:EFO_0022690, CLDB:cl117, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioGRID_ORCS_Cell_line:1757, BioSample:SAMN03473591, BioSample:SAMN10988566, cancercelllines:CVCL_0079, Cell_Model_Passport:SIDM01076, ChEMBL-Cells:CHEMBL3308147, ChEMBL-Targets:CHEMBL2366253, Cosmic:906800, Cosmic:1037742, Cosmic:1130252, Cosmic:1191693, Cosmic:1524788, Cosmic:2396142, Cosmic:2427693, Cosmic:2649230, Cosmic-CLP:906800, DepMap:ACH-000070, DSMZ:ACC-42, DSMZCellDive:ACC-42, EGA:EGAS00001000978, GDSC:906800, GEO:GSM236777, GEO:GSM236813, GEO:GSM886843, GEO:GSM887907, GEO:GSM1669562, GEO:GSM5137704, GEO:GSM5137749, IARC_TP53:21153, IZSLER:BS TCL 241, LiGeA:CCLE_726, LINCS_LDP:LCL-1042, Lonza:235, PharmacoDB:697_26_2019, PRIDE:PXD023662, PRIDE:PXD030304, Progenetix:CVCL_0079, PubChem_Cell_line:CVCL_0079, Wikidata:Q54604500 |
|
|
CVCL_0079 |
2026-02-07 08:59:35 |
11 |
786-O
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_1051
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:721102 PMID:1010528 PMID:2041050 PMID:6244232 PMID:7915601 PMID:9331090 PMID:10700174 PMID:15585611 PMID:15748285 PMID:17088437 PMID:19372543 PMID:20164919 PMID:22068913 PMID:22185343 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:22949125 PMID:23856246 PMID:23933261 PMID:24279929 PMID:24670534 PMID:25485619 PMID:25877200 PMID:25894527 PMID:25984343 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27377824 PMID:27397505 PMID:27807467 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30260228 PMID:30894373 PMID:31068700 PMID:31267758 PMID:31733513 PMID:31978347 PMID:35839778 PMID:38861359
|
Cancer cell line
|
Male |
786-o, 786O, 786-0, 786.O, 786-O RCC, RCC 786-O, RCC_7860, RCC 7860, 7860, 786-0WT |
|
|
BTO:BTO_0003781, CLO:CLO_0001486, EFO:EFO_0005707, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1932, BCRC:60243, BioGRID_ORCS_Cell_line:502, BioSample:SAMN03471906, BioSample:SAMN10988199, cancercelllines:CVCL_1051, CCRID:1101HUM-PUMC000243, CCRID:3101HUMSCSP5059, CCRID:3101HUMTCHu186, CCRID:4201HUM-CCTCC00159, CCRID:5301HUM-KCB09014YJ, CCTCC:GDC0159, Cell_Model_Passport:SIDM00125, ChEMBL-Cells:CHEMBL3308018, ChEMBL-Targets:CHEMBL613102, CLS:300107, Cosmic:687936, Cosmic:875874, Cosmic:897461, Cosmic:905947, Cosmic:972929, Cosmic:974305, Cosmic:982276, Cosmic:1044259, Cosmic:1092589, Cosmic:1175848, Cosmic:1305372, Cosmic:1312360, Cosmic:1481416, Cosmic:1998431, Cosmic:2036676, Cosmic:2520637, Cosmic:2663796, Cosmic-CLP:905947, DepMap:ACH-000649, EGA:EGAS00001000610, EGA:EGAS00001000978, ENCODE:ENCBS261AAA, ENCODE:ENCBS413VCR, ENCODE:ENCBS807WMR, GDSC:905947, GEO:GSM2128, GEO:GSM50226, GEO:GSM50290, GEO:GSM482711, GEO:GSM743488, GEO:GSM750838, GEO:GSM799371, GEO:GSM799377, GEO:GSM799434, GEO:GSM843437, GEO:GSM846283, GEO:GSM886845, GEO:GSM887909, GEO:GSM1153444, GEO:GSM1177874, GEO:GSM1177875, GEO:GSM1177876, GEO:GSM1181296, GEO:GSM1181322, GEO:GSM1669572, GEO:GSM2124635, IARC_TP53:18076, IARC_TP53:28222, IZSLER:BS TCL 124, KCB:KCB 200941YJ, LiGeA:CCLE_806, LINCS_LDP:LCL-1773, Lonza:1087, MetaboLights:MTBLS737, NCI-DTP:786-0, PharmacoDB:7860_28_2019, PRIDE:PXD000335, PRIDE:PXD000589, PRIDE:PXD001493, PRIDE:PXD003105, PRIDE:PXD003539, PRIDE:PXD005453, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD030304, Progenetix:CVCL_1051, PubChem_Cell_line:CVCL_1051, SKY/M-FISH/CGH:2782, Ubigene:YC-C113, Wikidata:Q54604950 |
|
|
CVCL_1051 |
2026-02-07 08:59:34 |
1478 |
769-P
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1050
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:721102 PMID:1010528 PMID:6244232 PMID:17178751 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
769P, 769-p |
|
|
BTO:BTO_0006376, CLO:CLO_0001485, EFO:EFO_0002099, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1933, BioGRID_ORCS_Cell_line:501, BioSample:SAMN03473275, BioSample:SAMN10988198, cancercelllines:CVCL_1050, CCRID:1101HUM-PUMC000333, CCRID:3101HUMSCSP5060, CCRID:3101HUMTCHu215, CCRID:4201HUM-CCTCC00103, CCTCC:GDC0103, Cell_Model_Passport:SIDM00803, ChEMBL-Cells:CHEMBL3308705, ChEMBL-Targets:CHEMBL1075385, CLS:300106, Cosmic:687935, Cosmic:801355, Cosmic:910922, Cosmic:982280, Cosmic:1779197, Cosmic:2520640, Cosmic-CLP:910922, DepMap:ACH-000411, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910922, GEO:GSM374479, GEO:GSM827256, GEO:GSM886844, GEO:GSM887908, GEO:GSM1669571, IARC_TP53:21154, IGRhCellID:769P, IZSLER:BS TCL 123, KCB:KCB 2013031YJ, LiGeA:CCLE_445, LINCS_LDP:LCL-1772, PharmacoDB:769P_27_2019, PRIDE:PXD030304, Progenetix:CVCL_1050, PubChem_Cell_line:CVCL_1050, Wikidata:Q54604830 |
|
|
CVCL_1050 |
2026-02-07 08:59:33 |
188 |
769-P
Resource Report
Resource Website
100+ mentions
|
CCTCC Cat# GDC0103, RRID:CVCL_1050
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:721102 PMID:1010528 PMID:6244232 PMID:17178751 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
769P, 769-p |
CCTCC |
GDC0103 |
BTO:BTO_0006376, CLO:CLO_0001485, EFO:EFO_0002099, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1933, BioGRID_ORCS_Cell_line:501, BioSample:SAMN03473275, BioSample:SAMN10988198, cancercelllines:CVCL_1050, CCRID:1101HUM-PUMC000333, CCRID:3101HUMSCSP5060, CCRID:3101HUMTCHu215, CCRID:4201HUM-CCTCC00103, CCTCC:GDC0103, Cell_Model_Passport:SIDM00803, ChEMBL-Cells:CHEMBL3308705, ChEMBL-Targets:CHEMBL1075385, CLS:300106, Cosmic:687935, Cosmic:801355, Cosmic:910922, Cosmic:982280, Cosmic:1779197, Cosmic:2520640, Cosmic-CLP:910922, DepMap:ACH-000411, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910922, GEO:GSM374479, GEO:GSM827256, GEO:GSM886844, GEO:GSM887908, GEO:GSM1669571, IARC_TP53:21154, IGRhCellID:769P, IZSLER:BS TCL 123, KCB:KCB 2013031YJ, LiGeA:CCLE_445, LINCS_LDP:LCL-1772, PharmacoDB:769P_27_2019, PRIDE:PXD030304, Progenetix:CVCL_1050, PubChem_Cell_line:CVCL_1050, Wikidata:Q54604830 |
|
|
CVCL_1050 |
2026-02-07 08:59:33 |
188 |
769-P
Resource Report
Resource Website
100+ mentions
|
KCB Cat# KCB 2013031YJ, RRID:CVCL_1050
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:721102 PMID:1010528 PMID:6244232 PMID:17178751 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
769P, 769-p |
KCB |
KCB 2013031YJ |
BTO:BTO_0006376, CLO:CLO_0001485, EFO:EFO_0002099, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1933, BioGRID_ORCS_Cell_line:501, BioSample:SAMN03473275, BioSample:SAMN10988198, cancercelllines:CVCL_1050, CCRID:1101HUM-PUMC000333, CCRID:3101HUMSCSP5060, CCRID:3101HUMTCHu215, CCRID:4201HUM-CCTCC00103, CCTCC:GDC0103, Cell_Model_Passport:SIDM00803, ChEMBL-Cells:CHEMBL3308705, ChEMBL-Targets:CHEMBL1075385, CLS:300106, Cosmic:687935, Cosmic:801355, Cosmic:910922, Cosmic:982280, Cosmic:1779197, Cosmic:2520640, Cosmic-CLP:910922, DepMap:ACH-000411, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910922, GEO:GSM374479, GEO:GSM827256, GEO:GSM886844, GEO:GSM887908, GEO:GSM1669571, IARC_TP53:21154, IGRhCellID:769P, IZSLER:BS TCL 123, KCB:KCB 2013031YJ, LiGeA:CCLE_445, LINCS_LDP:LCL-1772, PharmacoDB:769P_27_2019, PRIDE:PXD030304, Progenetix:CVCL_1050, PubChem_Cell_line:CVCL_1050, Wikidata:Q54604830 |
|
|
CVCL_1050 |
2026-02-07 08:59:37 |
188 |
42-MG-BA
Resource Report
Resource Website
|
RRID:CVCL_1798
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9604998 PMID:22460905 PMID:26589293 PMID:27397505 PMID:28464039 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
42MGBA |
|
|
CLO:CLO_0001367, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:440, BioSample:SAMN03473596, BioSample:SAMN10988275, cancercelllines:CVCL_1798, Cell_Model_Passport:SIDM00982, Cosmic:687561, Cosmic:1746946, Cosmic:1995325, Cosmic:2060804, Cosmic:2302328, Cosmic:2732518, Cosmic-CLP:687561, DepMap:ACH-000323, DSMZ:ACC-431, DSMZCellDive:ACC-431, EGA:EGAS00001000978, GDSC:687561, GEO:GSM326214, GEO:GSM886839, GEO:GSM887902, GEO:GSM1669567, IARC_TP53:28274, LiGeA:CCLE_146, LINCS_LDP:LCL-1347, PharmacoDB:42MGBA_16_2019, PRIDE:PXD030304, Progenetix:CVCL_1798, Wikidata:Q54603004 |
|
|
CVCL_1798 |
2026-02-07 08:59:26 |
0 |
451Lu
Resource Report
Resource Website
1+ mentions
Discontinued Possibly Discontinued
|
RRID:CVCL_6357
|
Homo sapiens (Human)
|
Cutaneous melanoma
|
Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: CSF1PO., Characteristics: Metastatic. Established from the lung of a nude mouse after 4 sequential passages of the parent cell line (PubMed=2156614)., Population: Caucasian., Part of: Wistar Institute melanoma cell line collection., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2068080 PMID:2156614 PMID:2253310 PMID:2918552 PMID:8342600 PMID:15592718 PMID:17260012 PMID:18632627 PMID:18790768 PMID:19340423 PMID:21156289 PMID:21343389 PMID:23285177 PMID:23851445 PMID:24055054 PMID:25056119 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
451LU, 451-LU, WM 451-Lu, WM-451Lu, WM-451LU, WM451Lu, WM451, WC00059, LU451, Lu451, EST81 |
|
|
BTO:BTO_0003710, CLO:CLO_0001373, ArrayExpress:E-MTAB-3610, ATCC:CRL-2813, BioSample:SAMN03471798, cancercelllines:CVCL_6357, Cell_Model_Passport:SIDM01240, ChEMBL-Cells:CHEMBL4802054, Coriell:WC00059, Cosmic:686411, Cosmic:1047656, Cosmic:1155281, Cosmic:1155568, Cosmic:1187587, Cosmic:1303027, Cosmic:2163808, Cosmic:2230114, Cosmic-CLP:1287706, DepMap:ACH-001002, EGA:EGAS00001000978, ESTDAB:ESTDAB-081, GDSC:1287706, GEO:GSM156019, GEO:GSM188238, GEO:GSM188268, GEO:GSM188327, GEO:GSM555137, GEO:GSM555187, GEO:GSM952579, GEO:GSM1199178, GEO:GSM1669568, IARC_TP53:26083, PharmacoDB:451Lu_17_2019, PRIDE:PXD030304, Progenetix:CVCL_6357, PubChem_Cell_line:CVCL_6357, Rockland:451Lu-01-0001, Wikidata:Q54603178 |
cvcl_7928 |
|
CVCL_6357 |
2026-02-07 08:59:15 |
7 |
L-540
Resource Report
Resource Website
1+ mentions
|
CLS Cat# 300201, RRID:CVCL_1362
|
Homo sapiens (Human)
|
Hodgkin lymphoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2690233 PMID:6303739 PMID:6305805 PMID:7276066 PMID:7530238 PMID:8558920 PMID:11021758 PMID:12581897 PMID:17065008 PMID:20164919 PMID:20628145 PMID:22460905 PMID:25355872 PMID:25894527 PMID:26589293 PMID:27397505 PMID:29533902 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
L 540, L540 |
CLS |
300201 |
BTO:BTO_0005176, CLO:CLO_0007201, EFO:EFO_0022416, CLDB:cl455, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473399, BioSample:SAMN10988507, cancercelllines:CVCL_1362, Cell_Model_Passport:SIDM00329, ChEMBL-Cells:CHEMBL3308531, ChEMBL-Targets:CHEMBL2366153, CLS:300201, Cosmic:907323, Cosmic:988705, Cosmic:1013911, Cosmic:1086359, Cosmic:1432039, Cosmic:2276327, Cosmic:2464307, Cosmic-CLP:907323, DepMap:ACH-000806, DSMZ:ACC-72, DSMZCellDive:ACC-72, EGA:EGAS00001000978, GDSC:907323, GEO:GSM335392, GEO:GSM499725, GEO:GSM499726, GEO:GSM552448, GEO:GSM646532, GEO:GSM646535, GEO:GSM887261, GEO:GSM888336, GEO:GSM1670030, IARC_TP53:21456, IARC_TP53:23615, LiGeA:CCLE_220, LINCS_LDP:LCL-2012, PharmacoDB:L540_816_2019, PRIDE:PXD000589, PRIDE:PXD030304, Progenetix:CVCL_1362, PubChem_Cell_line:CVCL_1362, Wikidata:Q54900876 |
|
|
CVCL_1362 |
2026-02-07 08:56:43 |
3 |
MS751
Resource Report
Resource Website
1+ mentions
|
Ubigene Cat# YC-C123, RRID:CVCL_4996
|
Homo sapiens (Human)
|
Human papillomavirus-related cervical squamous cell carcinoma
|
Virology: Contains a partial HPV45 genome., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080 PMID:2990217 PMID:3518877 PMID:6935474 PMID:7459858 PMID:9049418 PMID:15531914 PMID:24134916 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:29156801 PMID:30894373 PMID:35839778
|
Cancer cell line
|
Female |
MS-751, MS 751 |
Ubigene |
YC-C123 |
CLO:CLO_0007878, EFO:EFO_0006456, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:HTB-34, BioSample:SAMN03472742, BioSample:SAMN03473089, cancercelllines:CVCL_4996, CCRID:3101HUMSCSP537, CCRID:3101HUMTCHu178, Cell_Model_Passport:SIDM00638, CLS:305115, Cosmic:928910, Cosmic:1071904, Cosmic:1131523, Cosmic:1176606, Cosmic:1193034, Cosmic:1201772, Cosmic:1995514, Cosmic:2816216, Cosmic-CLP:1240179, DepMap:ACH-001360, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1240179, GEO:GSM113865, GEO:GSM253301, GEO:GSM675737, GEO:GSM685439, GEO:GSM1670135, IARC_TP53:27233, IGRhCellID:MS751, LINCS_LDP:LCL-1306, PharmacoDB:MS751_967_2019, PRIDE:PXD030304, Progenetix:CVCL_4996, Ubigene:YC-C123, Wikidata:Q54906811 |
|
|
CVCL_4996 |
2026-02-07 08:56:58 |
1 |
NK-92MI
Resource Report
Resource Website
10+ mentions
Discontinued Possibly Discontinued
|
BCRC Cat# 60438, RRID:CVCL_3755
|
Homo sapiens (Human)
|
Natural killer cell lymphoblastic leukemia/lymphoma
|
Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers of NK-92MI. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support., Characteristics: No longer dependent on IL2., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:10365666 PMID:27397505 PMID:30894373 PMID:35839778
|
Cancer cell line
|
Male |
NK-92 MI, NK-92 mi, NK92-MI, NK92MI, NK-92 transfected with MFG-hIL2 |
BCRC |
60438 |
CLO:CLO_0008178, ATCC:CRL-2408, BCRC:60438, cancercelllines:CVCL_3755, CCRID:1102HUM-NIFDC00065, Cell_Model_Passport:SIDM01201, Cosmic-CLP:1330981, DepMap:ACH-002289, GDSC:1330981, GEO:GSM1670278, KCB:KCB 200677YJ, LINCS_LDP:LCL-1127, PharmacoDB:NK92MI_1160_2019, PRIDE:PXD030304, Wikidata:Q54930658 |
cvcl_2142 |
|
CVCL_3755 |
2026-02-07 08:56:51 |
17 |
NK-92MI
Resource Report
Resource Website
10+ mentions
Discontinued Possibly Discontinued
|
ATCC Cat# CRL-2408, RRID:CVCL_3755
|
Homo sapiens (Human)
|
Natural killer cell lymphoblastic leukemia/lymphoma
|
Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers of NK-92MI. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support., Characteristics: No longer dependent on IL2., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:10365666 PMID:27397505 PMID:30894373 PMID:35839778
|
Cancer cell line
|
Male |
NK-92 MI, NK-92 mi, NK92-MI, NK92MI, NK-92 transfected with MFG-hIL2 |
ATCC |
CRL-2408 |
CLO:CLO_0008178, ATCC:CRL-2408, BCRC:60438, cancercelllines:CVCL_3755, CCRID:1102HUM-NIFDC00065, Cell_Model_Passport:SIDM01201, Cosmic-CLP:1330981, DepMap:ACH-002289, GDSC:1330981, GEO:GSM1670278, KCB:KCB 200677YJ, LINCS_LDP:LCL-1127, PharmacoDB:NK92MI_1160_2019, PRIDE:PXD030304, Wikidata:Q54930658 |
cvcl_2142 |
|
CVCL_3755 |
2026-02-07 08:56:51 |
17 |
ACC-MESO-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_5113
|
Homo sapiens (Human)
|
Pleural epithelioid mesothelioma
|
Donor information: No history of asbestos exposure (PubMed=16630136)., Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:16630136 PMID:17270034 PMID:21245096 PMID:22460905 PMID:25902174 PMID:26011428 PMID:26589293 PMID:28553954 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Female |
ACC-Meso-1, ACCMESO1, MESO-1 |
|
|
CLO:CLO_0050082, ArrayExpress:E-MTAB-2770, BioSample:SAMN03471958, BioSample:SAMN10987705, cancercelllines:CVCL_5113, Cell_Model_Passport:SIDM01526, Cosmic:877273, Cosmic:1481540, Cosmic:2759002, Cosmic:2759214, DepMap:ACH-000086, FANTOM5_SSTAR:10493-107B7, GEO:GSM551967, GEO:GSM850296, GEO:GSM886862, GEO:GSM887927, IARC_TP53:24548, IARC_TP53:30221, LiGeA:CCLE_096, PharmacoDB:ACCMESO1_52_2019, Progenetix:CVCL_5113, RCB:RCB2292, Wikidata:Q54608242 |
|
|
CVCL_5113 |
2026-02-07 09:00:50 |
5 |